Get the Stockscreener App
1.16
4.13%
-0.05
Werewolf Therapeutics Inc stock is traded at $1.16, with a volume of 182.68K.
It is down -4.13% in the last 24 hours and up +10.48% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$1.21
Open:
$1.21
24h Volume:
182.68K
Relative Volume:
0.36
Market Cap:
$52.05M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-1.1154
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
-14.71%
1M Performance:
+10.48%
6M Performance:
-13.43%
1Y Performance:
-49.57%
1-Day Range:
$1.15
$1.22
1-Week Range:
$1.15
$1.43
52-Week Range:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.16 | 54.30M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Short interest data insights for Werewolf Therapeutics Inc.Free Day Trading Signals With High Precision - Newser
Can swing trading help recover from Werewolf Therapeutics Inc. lossesEntry Timing Tracker with Alert Accuracy - Newser
Why Werewolf Therapeutics Inc. is moving todayScalable Strategy with Chart Confirmation - Newser
What machine learning models say about Werewolf Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
How Werewolf Therapeutics Inc. stock performs during market volatilityConservative Equity Setup with Signal Analysis - Newser
What is the dividend policy of Werewolf Therapeutics Inc. stockPre Market Trend Scanner From AI Tools - jammulinksnews.com
Why is Werewolf Therapeutics Inc. stock attracting strong analyst attentionBeginner Investor Insights Backed By Experts - jammulinksnews.com
What the charts say about Werewolf Therapeutics Inc. todaySwing Entry Risk Mitigation with Chart Analysis - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potentialRisk Aware Trading Ideas with Alert Levels - Newser
What earnings revisions data tells us about Werewolf Therapeutics Inc.Free ROI Driven Equity Selection With Safety - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategiesReal Time Screener for Growth Trades - Newser
Is Werewolf Therapeutics Inc. Stock a Good Fit for Conservative InvestorsLow Volatility Stock Analysis With Confidence - Newser
What makes Werewolf Therapeutics Inc. stock price move sharplyAI Trend Detection for Entry Timing - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionReversal Pattern Insights with Entry Tips - Newser
Visual analytics tools that track Werewolf Therapeutics Inc. performanceFree Sector Rotation Based Trading Opportunities - Newser
Live market analysis of Werewolf Therapeutics Inc.Momentum Trading Guide with Safety Limits - Newser
Using data filters to optimize entry into Werewolf Therapeutics Inc.Quick Profit Setup with Signal Forecast - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trendsLong Term Stock Planner with Safety Checks - Newser
Key External Factors That Drive Werewolf Therapeutics Inc. Stock Price MovementsPrice Action Trading with Volume Confirmation - Newser
Screener Results Flag Werewolf Therapeutics Inc. as OversoldSector Based Breakout Stock Forecast Issued - metal.it
Published on: 2025-07-29 03:06:26 - metal.it
Should I hold or sell Werewolf Therapeutics Inc. stock in 2025Entry Signal Data Feed With Low Risk - jammulinksnews.com
What institutional investors are buying Werewolf Therapeutics Inc. stockPowerful profit generation - jammulinksnews.com
What are Werewolf Therapeutics Inc. company’s key revenue driversEntry Signal Data Feed With Low Risk - jammulinksnews.com
Live market analysis of Werewolf Therapeutics Inc. High Conviction Stock Long-Term Summary - Newser
What the charts say about Werewolf Therapeutics Inc. today Forecasting Stock Moves with AI Insights - Newser
How Resilient Is Werewolf Therapeutics Inc. Stock During Economic Downturns Swing Trade Timing with Daily Forecast - metal.it
How many analysts rate Werewolf Therapeutics Inc. as a “Buy”Build a portfolio that stands the test of time - jammulinksnews.com
When is Werewolf Therapeutics Inc. stock expected to show significant growthDynamic investment growth - jammulinksnews.com
What are the technical indicators suggesting about Werewolf Therapeutics Inc.Outstanding growth strategies - jammulinksnews.com
What catalysts could drive Werewolf Therapeutics Inc. stock higher in 2025High-impact investment strategies - jammulinksnews.com
How does Werewolf Therapeutics Inc. generate profit in a changing economyCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What is the risk reward ratio of investing in Werewolf Therapeutics Inc. stockInvest smarter with daily market updates - jammulinksnews.com
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Werewolf Therapeutics Inc Stock (HOWL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):